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Résumé en
anglais
The IGF1 generation test (IGFGT) is often used during the assessment of suspected
GH insensitivity (GHI). We report the results of a survey undertaken in 2010 to
determine the use of IGFGT amongst members of the European Society for
Paediatric Endocrinology to evaluate suspected GHI. The literature surrounding
the usefulness and limitations of IGFGT are reviewed, and recommendations
provided for its use. Of 112 paediatric endocrinologists from 30 countries who
responded to the survey, 91 (81%) reported that they had used the IGFGT in the
previous 2 years; >10 IGFGT protocols were used. The IGFGT impacted treatment
decisions for 97% of the respondents and was a prerequisite for recombinant
human IGF1 treatment for 45% of respondents. From a literature review,
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